RAPT Therapeutics (RAPT) Other Non-Current Assets: 2020-2024
Historic Other Non-Current Assets for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $389,000.
- Therapeutics' Other Non-Current Assets fell 90.75% to $389,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $389,000, marking a year-over-year decrease of 90.75%. This contributed to the annual value of $3.9 million for FY2023, which is 4.09% down from last year.
- As of Q3 2024, Therapeutics' Other Non-Current Assets stood at $389,000, which was down 12.98% from $447,000 recorded in Q2 2024.
- Over the past 5 years, Therapeutics' Other Non-Current Assets peaked at $4.3 million during Q2 2023, and registered a low of $389,000 during Q1 2020.
- Moreover, its 3-year median value for Other Non-Current Assets was $3.1 million (2022), whereas its average is $2.8 million.
- Per our database at Business Quant, Therapeutics' Other Non-Current Assets soared by 694.60% in 2022 and then plummeted by 90.75% in 2024.
- Over the past 5 years, Therapeutics' Other Non-Current Assets (Quarterly) stood at $389,000 in 2020, then spiked by 651.16% to $2.9 million in 2021, then skyrocketed by 38.12% to $4.0 million in 2022, then decreased by 4.09% to $3.9 million in 2023, then tumbled by 90.75% to $389,000 in 2024.
- Its last three reported values are $389,000 in Q3 2024, $447,000 for Q2 2024, and $447,000 during Q1 2024.